BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical has launched a new treatment option for otolaryngologists (ear, nose and throat specialists) who repair the dura mater following cerebrospinal fluid ...

Cook Medical has launched a new treatment option for otolaryngologists (ear, nose and throat specialists) who repair the dura mater following cerebrospinal fluid (CSF) leaks at the base of the skull.

Cook Medical is releasing its new hernia repair graft made out of the company’s proprietary Biodesign™ material that’s strong and resistant to infection. From a press release obtained by Medgadget: ...

Bloomington, Ind. - A five-year study confirms the long-term strength and durability of the Biodesign Hernia Graft, Cook Medical, a world leader in advanced tissue repair, announced today. The study, ...

BLOOMINGTON, Ind.--(BUSINESS WIRE)-- More than 40,000 U.S. health care providers will gain access to special pricing and terms for an advanced biologic graft for soft tissue repair through a ...

If you believe in your product you try to sell it to as many people as you can. If you are fanatical about your product you design a website to evangelize others to its use. Cook Medical produces a ...

For more than a decade, Cook Medical has been collaborating with Purdue University (West Lafayette, IN) to pioneer a breakthrough technology for the reinforcement and repair of damaged human tissue.

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical today released the first ever European research findings on anal fistula repair in conjunction with the Cook Medical symposium at the European Society ...

It still seems like science fiction to many, but for more than a decade now mankind has had the technology to regenerate human tissue to repair large or complex wounds resulting from burns, gashes, ...

Cook Medical has tread the most medically sensitive terrain yet with its versatile tissue-regeneration product. The base of the human brain. A tiny new version of Cook's Biodesign graft has been ...

Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of... Next-generation T-cell engager (TCE) ...